FloraWorks

Floraworks is a specialized supplier of hemp-derived cannabinoids for use in a wide variety of consumer and enterprise applications.

Recent News

Cannabinoid Biotech Leader FloraWorks to Present at Seed Showcase 2024 During J.P. Morgan Healthcare Conference
Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc., a leading cannabinoid therapeutics company, announced it will present at Seed Showcase, part of Biotech Showcase 2024, during this year's annual J.P. Morgan Healthcare Conference in San Francisco, CA. Attendees can view FloraWorks' presentation live during the in-person event on Tuesday, January 9th at 2:20 p.m. PT in the Franciscan-D presentation room.Lindquist will present the Company's groundbreaking approach to advance cannabinoid research for a new
2024-01-04 9:00 AM EST
Healthcare Industry Veteran Donald M. Casey Jr. Joins Board of Directors at Cannabinoid Biotech Leader FloraWorks
Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc., a leading cannabinoid biotech company, announced the appointment of Donald M. Casey Jr. as Board Director. Casey brings over 30 years of global healthcare experience to the FloraWorks board, with an outstanding track record of identifying and commercializing medical innovations.Casey has held numerous executive leadership and board tenures, starting with 24 years at Johnson & Johnson where he rose through the ranks to join the company's executive committee, becoming worldwide...
2024-01-04 9:00 AM EST
FloraWorks Appoints Cannabis Scientist Dr. Mike McCormick as VP of Strategy
Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc., a leading cannabinoid therapeutics company, announced the appointment of Dr. Mike McCormick as VP of Strategy. A science and intellectual property consultant for FloraWorks since 2022, Dr. McCormick brings extensive expertise in cannabinoid biochemistry, innovation, and IP protection.Within the cannabis industry, Dr. McCormick focuses on industrial and academic technology transfer, and the development of next-generation therapeutics, consumer products, scientific methods, and educational content. He has been consulting in the sector...
2023-10-04 9:00 AM EDT
FloraWorks Announces Updated Analysis of Landmark Clinical Trial; CBN Shown Effective for Sleep
Portland, Oregon--(Newsfile Corp. - September 18, 2023) - FloraWorks Holdings Inc., a leading cannabinoid therapeutics company, announced that its flagship product TruCBN™ (a pure form of cannabinol or "CBN") demonstrated effectiveness in treating sleep disturbances in a recent landmark clinical trial independently conducted by Radicle Science. In the industry-first, double-blind, randomized, placebo-controlled trial, 25, 50, and 100 milligrams of TruCBN™ were found to significantly enhance sleep outcomes and provide clinically
2023-09-18 9:00 AM EDT
FloraWorks Announces Scientific Breakthrough in Natural Sleep Aids: First-Ever Double-Blind, Randomized, Placebo-Controlled Clinical Trial Discovers CBN Effective for Sleep
Portland, Oregon--(Newsfile Corp. - June 28, 2023) - A landmark study led by FloraWorks Holdings Inc. ("FloraWorks" or "Company"), a leading cannabinoid therapeutics company, announced the results of the first-ever double-blind, randomized, placebo-controlled trial that analyzed the effects of its flagship product, TruCBN™ - a pure form of Cannabinol ("CBN") and one of more than 100 known cannabinoids found in the cannabis plant - on sleep. Independently conducted by clinical-research company, Radicle
2023-06-28 7:00 AM EDT
FloraWorks Closes $2.25M Series-A with Round Led by Bonaventure Equity
Portland, Oregon--(Newsfile Corp. - June 22, 2023) - FloraWorks Holdings Inc. ("FloraWorks" or "Company"), a leading cannabinoid therapeutics company that specializes in rare and novel cannabinoids, announced the successful completion of a $2.25M Series-A financing round. The round was led by Bonaventure Equity LLC ("BVE"), a life sciences venture capital firm investing in cannabinoid and psychedelic discoveries, with participation from ArcView Group, a global leader serving the cannabis and hemp industry, along with a high-n
2023-06-22 12:31 PM EDT
FloraWorks Announces the Closing of Lead Investor in Series A Financing
Portland, Oregon--(Newsfile Corp. - December 15, 2022) - FloraWorks Holdings Inc. (the "Company" or "FloraWorks"), a biotech company specializing in rare and novel cannabinoids, is pleased to announce the initial closing of its Series A financing with its lead investor BVE Select Fund II, L.P., the second life sciences venture fund of Bonaventure Equity, LLC ("BVE"). BVE's Founder and Managing Partner, Ross O'Brien, will be joining the Company's board of directors. This latest round of funding will support FloraWork's efforts...
2022-12-15 4:30 PM EST
CBN Has Become the Leading Growth Catalyst in the Cannabis Edible Market
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - FloraWorks Holdings Inc. ("FloraWorks" or the "Company") FloraWorks, is closely tracking the growth of CBN adoption within the hemp and cannabis industry. Using data from Headset, a leading cannabis market intelligence service, the company has created the Q1 2021 CBN Market Report to give you a glimpse into the early growth phase of the rapidly emerging market demand for CBN products.Cannabinol or CBN for short, is a rare cannabinoid once only...
2021-05-04 10:00 AM EDT
Also Known as "The Sleep Cannabinoid", Cannabinol (CBN) Is Now Available in Commercial Quantities
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) - FloraWorks Holdings Inc. ("FloraWorks" or the "Company") Cannabinol (CBN), the rare cannabinoid often only found in trace amounts of aged cannabis has been shown to have unique physiological effects that have already started gaining traction for consumer health applications. FloraWorks is excited to announce that after significant research and development efforts, the Company is now manufacturing highly-pure, hemp-derived CBN isolate at scale, that is now commercially available for sale.FloraWorks strives to...
2020-06-09 5:00 AM EDT

FloraWorks

Recent News

Get News by Email

RSS Feeds

Tell Us Your Story

Cookie Settings

Get News by Email

RSS Feeds

Tell Us Your Story